|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.00 INR | +1.42% |
|
-7.44% | -19.16% |
Company Valuation: Quest Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 |
|---|---|
| Market Cap 1 | 1,679 |
| Change | - |
| Enterprise Value (EV) 1 | 1,488 |
| Change | - |
| P/E | 12.4x |
| PBR | 2.05x |
| PEG | -5.93x |
| Capitalization / Revenue | 1.61x |
| EV / Revenue | 1.43x |
| EV / EBITDA | 8.44x |
| EV / EBIT | 8.75x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | - |
| Rate of return | - |
| EPS 2 | 8.279 |
| Distribution rate | - |
| Net sales 1 | 1,040 |
| EBITDA 1 | 176.3 |
| EBIT 1 | 170 |
| Net income 1 | 135.7 |
| Net Debt 1 | -190.8 |
| Reference price 2 | 102.45 |
| Nbr of stocks (in thousands) | 16,387 |
| Announcement Date | 9/4/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 15.02M | |
| 35.46x | 12.91x | 26.29x | 0.56% | 1,084B | |
| 28.11x | 6.45x | 17.52x | 2.03% | 634B | |
| 30.45x | 7.46x | 15.28x | 2.72% | 447B | |
| 17.81x | 4.43x | 10.97x | 2.99% | 330B | |
| 23.78x | 4.98x | 13.89x | 1.75% | 295B | |
| 21.66x | 5.57x | 13.46x | 2.83% | 285B | |
| 14.26x | 5.31x | 10.9x | 3.51% | 218B | |
| 24.07x | 6.37x | 11.22x | 2.74% | 199B | |
| -48.15x | 5.84x | 32.48x | 2.39% | 169B | |
| Average | 16.38x | 6.59x | 16.89x | 2.39% | 365.99B | |
| Weighted average by Cap. | 24.24x | 8.02x | 18.60x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- QUESTLAB Stock
- Valuation Quest Laboratories Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
